IGFBP4 Antikörper (N-Term)
Kurzübersicht für IGFBP4 Antikörper (N-Term) (ABIN2294823)
Target
Alle IGFBP4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- Insulin-Like Growth Factor Binding Protein 4, NT (IGF Binding Protein 4, IBP 4, IBP4, IBP-4, IGFBP 4, IGFBP4, IGFBP-4, BP 4, BP-4, HT29-IGFBP)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- Synthetic peptide selected from the N-terminal region of human IGFBP4 (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Andere Bezeichnung
- Insulin-Like Growth Factor Binding Protein 4
-
NCBI Accession
- NP_001543
-
UniProt
- P22692
-
Pathways
- WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
Target
-